tiprankstipranks
Trending News
More News >
Eli Lilly And Company (DE:LLY)
NYSE:LLY
Germany Market

Eli Lilly & Co (LLY) Drug Pipeline

Compare
188 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Imlunestrant, Imlunestrant + Goserelin, Tamoxifen 20 Mg, Pre-Filled Syringe
Breast Neoplasm Female
Phase II
Not Yet Recruiting
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Dec 11, 2025
Eloralintide
Obesity, Overweight
Phase III
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Dec 05, 2025
Ly4213663
Healthy, Rheumatoid Arthritis (Ra)
Phase I
Recruiting
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Nov 21, 2025
Ly4064809
Healthy
Phase I
Active Not Recruiting
A Study of LY4064809 in Healthy Adult Chinese Participants
Nov 18, 2025
Ly3549492
Healthy, Obesity, Overweight
Phase I
Recruiting
A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity
Nov 14, 2025
Rituximab, Ly4584180
Follicular Lymphoma, Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell
Phase I
Not Yet Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nov 07, 2025
Brenipatide
Smoking
Phase II
Recruiting
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Oct 31, 2025
Orforglipron
Peripheral Arterial Disease
Phase III
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Oct 30, 2025
Baricitinib
Diabetes Mellitus, Type 1
Phase III
Not Yet Recruiting
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Oct 27, 2025
Baricitinib
Diabetes Mellitus, Type 1
Phase III
Not Yet Recruiting
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Oct 27, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Eli Lilly And Company (LLY) have in its pipeline
      LLY is currently developing the following drugs: Imlunestrant, Imlunestrant + Goserelin, Tamoxifen 20 Mg, Pre-Filled Syringe, Eloralintide, Ly4213663. These drug candidates are in various stages of clinical development as the company works toward FDA approval.